Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,500 shares at $434.58 ($1.1M) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Scheduled sale ($1.1M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |
| VRTX | SELL | 2025-02-26 | $1.7M | — | Filing → |